1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Brain Disease Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Brain Cancer
  • 1.2.3 Alzheimer Disease
  • 1.2.4 Alcoholism
  • 1.2.5 Amnesia
  • 1.2.6 Epilepsy
  • 1.2.7 Meningitis
  • 1.2.8 Others
• 1.3 Market by Application
  • 1.3.1 Global Brain Disease Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals Pharmacy
  • 1.3.3 Online Pharmacy
  • 1.3.4 Pharmacy
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Brain Disease Market Perspective (2015-2026)
• 2.2 Global Brain Disease Growth Trends by Regions
  • 2.2.1 Brain Disease Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Brain Disease Historic Market Share by Regions (2015-2020)
  • 2.2.3 Brain Disease Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Brain Disease Players by Market Size
  • 3.1.1 Global Top Brain Disease Players by Revenue (2015-2020)
  • 3.1.2 Global Brain Disease Revenue Market Share by Players (2015-2020)
• 3.2 Global Brain Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Brain Disease Revenue
• 3.4 Global Brain Disease Market Concentration Ratio
  • 3.4.1 Global Brain Disease Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Brain Disease Revenue in 2019
• 3.5 Key Players Brain Disease Area Served
• 3.6 Key Players Brain Disease Product Solution and Service
• 3.7 Date of Enter into Brain Disease Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Brain Disease Breakdown Data by Type (2015-2026)

• 4.1 Global Brain Disease Historic Market Size by Type (2015-2020)
• 4.2 Global Brain Disease Forecasted Market Size by Type (2021-2026)

5 Brain Disease Breakdown Data by Application (2015-2026)

• 5.1 Global Brain Disease Historic Market Size by Application (2015-2020)
• 5.2 Global Brain Disease Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Brain Disease Market Size (2015-2026)
• 6.2 North America Brain Disease Market Size by Type (2015-2020)
• 6.3 North America Brain Disease Market Size by Application (2015-2020)
• 6.4 North America Brain Disease Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Brain Disease Market Size (2015-2026)
• 7.2 Europe Brain Disease Market Size by Type (2015-2020)
• 7.3 Europe Brain Disease Market Size by Application (2015-2020)
• 7.4 Europe Brain Disease Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Brain Disease Market Size (2015-2026)
• 8.2 China Brain Disease Market Size by Type (2015-2020)
• 8.3 China Brain Disease Market Size by Application (2015-2020)
• 8.4 China Brain Disease Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Brain Disease Market Size (2015-2026)
• 9.2 Japan Brain Disease Market Size by Type (2015-2020)
• 9.3 Japan Brain Disease Market Size by Application (2015-2020)
• 9.4 Japan Brain Disease Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Brain Disease Market Size (2015-2026)
• 10.2 Southeast Asia Brain Disease Market Size by Type (2015-2020)
• 10.3 Southeast Asia Brain Disease Market Size by Application (2015-2020)
• 10.4 Southeast Asia Brain Disease Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Pfizer Business Overview
  • 11.1.3 Pfizer Brain Disease Introduction
  • 11.1.4 Pfizer Revenue in Brain Disease Business (2015-2020))
  • 11.1.5 Pfizer Recent Development
• 11.2 Eli Lilly
  • 11.2.1 Eli Lilly Company Details
  • 11.2.2 Eli Lilly Business Overview
  • 11.2.3 Eli Lilly Brain Disease Introduction
  • 11.2.4 Eli Lilly Revenue in Brain Disease Business (2015-2020)
  • 11.2.5 Eli Lilly Recent Development
• 11.3 F. Hoffmann La Roche
  • 11.3.1 F. Hoffmann La Roche Company Details
  • 11.3.2 F. Hoffmann La Roche Business Overview
  • 11.3.3 F. Hoffmann La Roche Brain Disease Introduction
  • 11.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2015-2020)
  • 11.3.5 F. Hoffmann La Roche Recent Development
• 11.4 GE Healthcare
  • 11.4.1 GE Healthcare Company Details
  • 11.4.2 GE Healthcare Business Overview
  • 11.4.3 GE Healthcare Brain Disease Introduction
  • 11.4.4 GE Healthcare Revenue in Brain Disease Business (2015-2020)
  • 11.4.5 GE Healthcare Recent Development
• 11.5 Janssen Pharmaceuticals
  • 11.5.1 Janssen Pharmaceuticals Company Details
  • 11.5.2 Janssen Pharmaceuticals Business Overview
  • 11.5.3 Janssen Pharmaceuticals Brain Disease Introduction
  • 11.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2015-2020)
  • 11.5.5 Janssen Pharmaceuticals Recent Development
• 11.6 Abbvie
  • 11.6.1 Abbvie Company Details
  • 11.6.2 Abbvie Business Overview
  • 11.6.3 Abbvie Brain Disease Introduction
  • 11.6.4 Abbvie Revenue in Brain Disease Business (2015-2020)
  • 11.6.5 Abbvie Recent Development
• 11.7 AC Immune
  • 11.7.1 AC Immune Company Details
  • 11.7.2 AC Immune Business Overview
  • 11.7.3 AC Immune Brain Disease Introduction
  • 11.7.4 AC Immune Revenue in Brain Disease Business (2015-2020)
  • 11.7.5 AC Immune Recent Development
• 11.8 Allergan
  • 11.8.1 Allergan Company Details
  • 11.8.2 Allergan Business Overview
  • 11.8.3 Allergan Brain Disease Introduction
  • 11.8.4 Allergan Revenue in Brain Disease Business (2015-2020)
  • 11.8.5 Allergan Recent Development
• 11.9 Merck
  • 11.9.1 Merck Company Details
  • 11.9.2 Merck Business Overview
  • 11.9.3 Merck Brain Disease Introduction
  • 11.9.4 Merck Revenue in Brain Disease Business (2015-2020)
  • 11.9.5 Merck Recent Development
• 11.10 Novartis
  • 11.10.1 Novartis Company Details
  • 11.10.2 Novartis Business Overview
  • 11.10.3 Novartis Brain Disease Introduction
  • 11.10.4 Novartis Revenue in Brain Disease Business (2015-2020)
  • 11.10.5 Novartis Recent Development
• 11.11 AstraZeneca
  • 10.11.1 AstraZeneca Company Details
  • 10.11.2 AstraZeneca Business Overview
  • 10.11.3 AstraZeneca Brain Disease Introduction
  • 10.11.4 AstraZeneca Revenue in Brain Disease Business (2015-2020)
  • 10.11.5 AstraZeneca Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Brain Disease Scope and Market Size
Brain Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brain Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Brain Cancer
Alzheimer Disease
Alcoholism
Amnesia
Epilepsy
Meningitis
Others

Market segment by Application, split into
Hospitals Pharmacy
Online Pharmacy
Pharmacy

Based on regional and country-level analysis, the Brain Disease market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Brain Disease market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
Novartis
AstraZeneca